Erin Cross
Company: KROMATID
Job title: Vice President, Platform & Lead Development Scientist
Seminars:
Next-Gen Cytogenetic Genomic Integrity Assays for C> Development 12:00 pm
KROMATID’s single cell cytogenetic platform provides advanced characterization and data analysis of genomic integrity for gene modified cell therapies Nationwide Children’s CARNK novel allogeneic therapy utilized KROMATID’s platform to assist in characterizing the safety profile of their therapy for hematologic malignancies Cytogenetic testing provides critical orthogonal data for characterization of whole genome assessment of transgene integration and on-and-off target…Read more
day: Day 1- Manufacturing 1